All In Biotech

Drug Trial Radar · NCT03678129

GABA Pathways in Autism Spectrum Disorder (ASD)

Modulation of the Brain Excitatory/Inhibitory (E/I) Balance Through Neuronal Systems in Autism Spectrum Disorder (ASD)

Last checked: Nov 19, 2026Latest source record: Aug 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

109

Actual

Start

Dec 7, 2018

Primary completion

Jun 27, 2025

Study completion Jun 27, 2025

Sponsor

Lead sponsor
King's College LondonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 19, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study investigates the brain response to a single acute dose of a GABAa receptor acting drug (Benzodiazepine or positive allosteric modulator) compared to a single dose of placebo in adults with and without autism spectrum disorder.

Conditions

  • Autism Spectrum Disorder

Interventions

  • AZD7325_10Drug

    Single oral dose (10mg)

  • AZD7325_20Drug

    Single oral dose (20mg)

  • PlaceboDrug

    Single oral dose placebo (capsule)

  • ClobazamDrug

    Single dose (5mg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Brain activation and connectivity response to GABAergic stimulation as assessed by functional magnetic resonance imaging.Time frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year.
  2. Brain electrophysiological activity task-free electroencephalography (EEG)Time frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year
  3. Brain oscillations under sensory stimulationTime frame: Data collected on up to 3 visit days per participant. Completed within up to 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • King's College London

    London, London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.